Social Security
[용어속성] Term
Community engagement in the prevention and control of COVID-19: Insights from Vietnam
Covid-19의 예방 및 통제에 대한 지역 사회 참여 : 베트남의 통찰력
Research Article
[키워드] activity
analyzed
approach
approval
building
carried
Community
Compliance
contribute
Control
COVID-19
cross-sectional
Data collection
Decision making
determinant
Early detection
effective
effective response
Engagement
FIVE
foster
Government
groups
Health
health authorities
highlight
highlighting
Hospitalization
Households
IMPROVE
individual
Infection
infection control
insight
institutional review board
Isolation
knowledge
Local
lockdowns
migrant workers
mobilization
multi
organization
outcomes
prevention
Prevention and control
public health
qualitative data
quarantine
replicated
resource
resources
Result
risk
selected
sense
sensitization
social distancing
Social Security
steering committee
Structure
Study design
supervision
Support
thematic analysis
Travel
Trust
university
vice
was collected
was used
with COVID-19
zone
[DOI] 10.1371/journal.pone.0254432 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0254432 PMC 바로가기 [Article Type] Research Article
Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial
COVID-19 대유행 중 ARDS 환자의 임상 결과에 대한 정맥내 리도카인의 영향(LidoCovid): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
24 hour
24 hours
acute renal failure
acute respiratory distress
acute respiratory distress syndrome
Admission
adverse event
adverse events
age
albumin
All participant
All participants
Anti-inflammatory effects
approved
aPTT
ARDS
Atrial fibrillation
Bacterial
Berlin
Beta
Bicarbonate
biological sample
biological samples
blinded
Blinding
blockers
blood count
bolus
bronchospasm
cardiac rhythm
Cardiogenic shock
Care
care providers
Child bearing
clinical
Clinical data
Clinical outcome
clinical study
collected
Commission
comparator
complete blood count
Complication
computer-generated
Concentration
conducted
Consumption
control group
cough
COVID-19
COVID-19 pneumonia
Covid-19 subgroup
CRP
D-dimers
delirium
diagnostic
Disease progression
disorders
dissemination
distribution
Distribution ratio
dosage
Effect
element
ethics committee
evaluate the effect
evaluated
Evolution
experimental group
extubation
ferritin
fibrinogen
FiO2
followed by
following
form
France
French
Gas exchange
HCG
Hospitalized
hypnotics
ICU
IL-6
Ileus
Impact
incidence
include
inclusion criteria
Inflammation
Inflammatory marker
inflammatory markers
intensive care
intensive care unit
interval
intervention group
intravenous
Intubated
investigator
LDH
Length
lidocaine
Local
local anaesthetics
Local anesthetics
Lymphocytes
moderate
moderate to severe
Modification
molecular mechanisms of pharmacological action
Mortality
NaCl
number
objective
Older
opioids
outcome
Pandemia
PaO2
PaO2/FiO2 ratio
parallel group
participant
Patient
patients with ARDS
PCT
Phase 3
Placebo
placebo-controlled
Platelets
Pneumonia
pneumopathy
Pneumothorax
Prevent
Primary outcome
protection
Protective
protocol
QTc
random
randomisation
randomised
randomised controlled trial
randomize
Randomized
Randomly
receive
Recovery time
recruitment
Registered
Renal Dialysis
renal failure
report
respiratory distress
RT-PCR
Sample size
SARS-CoV2 infection
secondary endpoint
Secondary endpoints
sedated
Severe acute respiratory syndrome
severe ARDS
Shock
Social Security
Social security system
sore throat
status
Stratification
stroke
Study protocol
supplementary material
surgical
syndrome
tetraplegia
thromboembolic
Thromboembolic event
timepoint
Toxicity
Treatment
Trial
Trial registration
triglycerides
troponin
two group
two groups
university
vasopressors
Ventilation
ventilator
ventilator-free day
Ventilator-free days
website
women
written Informed Consent
[DOI] 10.1186/s13063-021-05095-x PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05095-x PMC 바로가기 [Article Type] Letter
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial
COVID-19 폐렴 환자에서 호흡 악화 예방을 위한 BIO101의 효능 및 안전성 테스트(COVA 연구): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
20-hydroxyecdysone
absence
accumulation
ACE2
Activation
acute respiratory distress
acute respiratory distress syndrome
adaptive
addition
administration
Airway Pressure
all-cause mortality
ALT
Alter
amenorrhea
Analysis
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
Angiotensin converting enzyme-2
Anti-inflammatory
anticipated
approved
ARDS
arterial oxygen saturation
AST
Asymptomatic
balance
baseline
being
Belgium
beneficiary
Bilirubin
BIO101
Biomarker
Biomarkers
birth control
blinded
Brazil
breath
Cardiomyopathy
Care
Caregivers
caused
clinical development
Clinical finding
Clinical findings
clinical picture
co-morbidities
co-morbidity
collected
Compliance
condition
condom
conducted
confirmation
Consumption
Continuous
Continuous Positive Airway Pressure
Contraception
contraceptive method
coronavirus disease
COVID-19
COVID-19 infection
COVID-19 infection symptom
COVID-19 infection symptoms
COVID-19 patient
COVID-19 patients
criteria
criterion
daily dose
Day
death
defined
Department
Deterioration
develop
diabetes
diagnosis of COVID-19
dialysis
discharge
discharged
disease
dissemination
DMC
dose
double-blind
downstream
ECMO
Effect
effective
Efficacy
Efficacy and safety
EGFR
element
eligible participant
Eligible participants
endotracheal tube
Endpoint
enzyme
etonogestrel
EudraCT
European
evaluate
event
Evidence
evidence of
exclusion criteria
expected
exploratory
extracorporeal membrane oxygenation
female
female participants
Final
FiO2
Flow
following
form
France
French
functional
Gault
Gender
healthcare
healthcare facility
heart disease
High-flow oxygen
higher risk
hospital
hospital care
Hospitalization
Hospitalized
hypersensitivity
hypertension
IBM
ICF
Imbalance
include
Inclusion
independent
indication
Infection
Inflammation
informed consent form
injection
Interim analyses
interim analysis
Intervention
intrauterine device
Intubated
Invasive mechanical ventilation
IWRS system
lactating
limit
Liver function
liver function tests
male participants
marker
Mas receptor
maximum
measure
mechanical ventilation
medical intervention
medication
medications
minute
moderate
morbidities
Moribund
Mortality
mouth
Multiorgan dysfunction
muscles
myocarditis
negative urine pregnancy test
Non-COVID-19
number
obesity
objective
observation
offer
Older
oral contraceptive
outcome
outlined
oxygen
Part
participant
partner
pathway
Pathways
patients with COVID-19
patients with SARS-CoV-2
PCR
performed
Pericarditis
Physical examination
Placebo
placebo-controlled
Pneumonia
positive airway pressure
post-intervention
post-menopausal
powder
pregnancy test
pressure
primary endpoint
proof
proportion
Proportion of participant
protocol
public health
randomised
randomised controlled trial
randomization
RAS
reached
receive
receiving
receptor
recruited
recruitment
Registered
renal
renal disease
renal insufficiency
Renin
renin angiotensin system
renin-angiotensin system
reproduction
required
resource
respiratory
Respiratory distress syndrome
Respiratory failure
Respiratory function
respiratory symptoms
restored
risk
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2
SARS-CoV2 spike protein
second
secondary
secondary endpoint
security
severe pneumonia
Shock
Social Security
specimen
Sperm
Spike protein
SpO2
Statistical power
status
Sterilization
Stratification
stratified
study medication
Study protocol
supplementary material
survival
suspicion
Symptom
syndrome
tachypnea
target population
tested
Testing
the primary endpoint
therapeutic
therapeutic option
tissue
Tolerability
Total
total bilirubin
Treatment
treatment arm
treatment period
Triage
Trial
Trial registration
ULN
Urine
USA
variety
vasectomy
Version
Viral load
water
website
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter
Identificación y selección de enfermedad de posible origen laboral atendida por el sistema público de salud
Originales
[키워드] Enfermedad profesional
national health system
occupational disease
Seguridad social
Sistema Nacional de Salud
Social Security
[DOI] 10.1016/j.aprim.2010.09.019 PMC 바로가기 [Article Type] Originales
[DOI] 10.1016/j.aprim.2010.09.019 PMC 바로가기 [Article Type] Originales